Ind-Swift Labs Allots 14 Lakh Equity Shares on Warrant Conversion

Ind-Swift Laboratories Limited announced the outcome of its Preferential Issue Committee Meeting held on October 8, 2026. The committee approved the allotment of 14,00,000 Equity Shares, face value ₹10 each, upon conversion of 14,00,000 Fully Convertible Warrants. These warrants were originally allotted on September 17, 2026, at an issue price of ₹196 per warrant. The conversion was made upon receipt of the balance 75% consideration of ₹147 per warrant, aggregating to ₹20,58,00,000 (₹20.58 Crore). The shares were allotted to Essix Biosciences Limited, part of the Promoter & Promoter Group. This allotment increases the company's paid-up equity share capital from ₹86,71,15,580 to ₹86,96,15,580.